Title:
抗悪性腫瘍剤組成物
Document Type and Number:
Japanese Patent JPWO2015173970
Kind Code:
A1
Abstract:
【課題】 新規抗悪性腫瘍剤組成物の提供【解決手段】ＬＡＴ１阻害剤と、アルキル化薬、白金製剤、代謝拮抗剤、トポイソメラーゼ阻害薬、微小管重合阻害薬、内分泌療法剤、微小管脱重合阻害薬、抗腫瘍性抗生物質及び分子標的薬からなる群より選択される一以上の剤と、を有効成分として含む抗悪性腫瘍剤組成物。【選択図】 なし
More Like This:
Inventors:
Hitoshi Endo
Wemp, Michael F
Peyron, Jean-Francois
Naohiko Anzai
Jutaba, Promsk
Wemp, Michael F
Peyron, Jean-Francois
Naohiko Anzai
Jutaba, Promsk
Application Number:
JP2014557910A
Publication Date:
April 20, 2017
Filing Date:
June 07, 2014
Export Citation:
Assignee:
J-Pharma Co., Ltd.
International Classes:
A61K45/06; A61K31/282; A61K31/416; A61K31/436; A61K31/513; A61K31/5377; A61K31/54; A61K31/69; A61K31/704; A61K31/7068; A61K33/243; A61P35/00; A61P35/02
Foreign References:
| WO2008081537A1 | 2008-07-10 |
Other References:
ＣＡＮＣＥＲ ＬＥＴＴＥＲＳ, vol. 276, no. 1, JPN6014036137, 2009, pages 95 - 101, ISSN: 0003807319
ＯＮＣＯＴＡＲＧＥＴ, vol. 3, no. 8, JPN6014036153, 2012, pages 811 - 823, ISSN: 0003807327
ＪＯＵＲＮＡＬ ＯＦ ＣＬＩＮＩＣＡＬ ＩＮＶＥＳＴＩＧＡＴＩＯＮ, vol. 118, no. 9, JPN6014036154, 2008, pages 3038 - 3050, ISSN: 0003807328
ＢＩＯＣＨＥＭＩＣＡＬ ＡＮＤ ＢＩＯＰＨＹＳＩＣＡＬ ＲＥＳＥＡＲＣＨ ＣＯＭＭＵＮＩＣＡＴＩＯＮ, vol. 439, no. 1, JPN6014036138, 2013, pages 103 - 108, ISSN: 0003807320
ＶＥＴＥＲＩＮＡＲＹ ＪＯＵＲＮＡＬ, vol. 198, no. 1, JPN6014036139, 2013, pages 164 - 169, ISSN: 0003807321
ＥＸＰＥＲＩＭＥＮＴＡＬ ＣＥＬＬ ＲＥＳＥＡＲＣＨ, vol. 315, no. 3, JPN6018009567, 2009, pages 485 - 497, ISSN: 0003807322
ＣＡＮＣＥＲ ＳＣＩＥＮＣＥ, vol. 101, no. 1, JPN6014036145, 2010, pages 173 - 179, ISSN: 0003807323
ＢＩＯＣＨＩＭＩＣＡ ＥＴ ＢＩＯＰＨＹＳＩＣＡ ＡＣＴＡ, vol. 1514, no. 2, JPN6014036142, 2001, pages 291 - 302, ISSN: 0003807324
ＪＯＵＲＮＡＬ ＯＦ ＰＨＡＲＭＡＣＯＬＯＧＩＣＡＬ ＳＣＩＥＮＣＥＳ, vol. 124, no. 2, JPN6014036144, February 2014 (2014-02-01), pages 208 - 217, ISSN: 0003807325
ＤＲＵＧ ＤＥＬＩＶＥＲＹ ＳＹＳＴＥＭ, vol. 27, no. 5, JPN6014036146, 2012, pages 342 - 349, ISSN: 0003807326
癌と化学療法, vol. 21, no. 4, JPN6018019885, 1994, pages 517 - 523, ISSN: 0003807329
ＮＥＷ ＥＮＧＬＡＮＤ ＪＯＵＲＮＡＬ ＯＦ ＭＥＤＩＣＩＮＥ, vol. 369, no. 18, JPN6018019889, 2013, pages 1691 - 1703, ISSN: 0003807330
ＡＮＴＩＣＡＮＣＥＲ ＲＥＳＥＡＲＣＨ, vol. 30, no. 11, JPN6018019892, 2010, pages 4619 - 4624, ISSN: 0003807331
ＯＮＣＯＴＡＲＧＥＴ, vol. 3, no. 8, JPN6014036153, 2012, pages 811 - 823, ISSN: 0003807327
ＪＯＵＲＮＡＬ ＯＦ ＣＬＩＮＩＣＡＬ ＩＮＶＥＳＴＩＧＡＴＩＯＮ, vol. 118, no. 9, JPN6014036154, 2008, pages 3038 - 3050, ISSN: 0003807328
ＢＩＯＣＨＥＭＩＣＡＬ ＡＮＤ ＢＩＯＰＨＹＳＩＣＡＬ ＲＥＳＥＡＲＣＨ ＣＯＭＭＵＮＩＣＡＴＩＯＮ, vol. 439, no. 1, JPN6014036138, 2013, pages 103 - 108, ISSN: 0003807320
ＶＥＴＥＲＩＮＡＲＹ ＪＯＵＲＮＡＬ, vol. 198, no. 1, JPN6014036139, 2013, pages 164 - 169, ISSN: 0003807321
ＥＸＰＥＲＩＭＥＮＴＡＬ ＣＥＬＬ ＲＥＳＥＡＲＣＨ, vol. 315, no. 3, JPN6018009567, 2009, pages 485 - 497, ISSN: 0003807322
ＣＡＮＣＥＲ ＳＣＩＥＮＣＥ, vol. 101, no. 1, JPN6014036145, 2010, pages 173 - 179, ISSN: 0003807323
ＢＩＯＣＨＩＭＩＣＡ ＥＴ ＢＩＯＰＨＹＳＩＣＡ ＡＣＴＡ, vol. 1514, no. 2, JPN6014036142, 2001, pages 291 - 302, ISSN: 0003807324
ＪＯＵＲＮＡＬ ＯＦ ＰＨＡＲＭＡＣＯＬＯＧＩＣＡＬ ＳＣＩＥＮＣＥＳ, vol. 124, no. 2, JPN6014036144, February 2014 (2014-02-01), pages 208 - 217, ISSN: 0003807325
ＤＲＵＧ ＤＥＬＩＶＥＲＹ ＳＹＳＴＥＭ, vol. 27, no. 5, JPN6014036146, 2012, pages 342 - 349, ISSN: 0003807326
癌と化学療法, vol. 21, no. 4, JPN6018019885, 1994, pages 517 - 523, ISSN: 0003807329
ＮＥＷ ＥＮＧＬＡＮＤ ＪＯＵＲＮＡＬ ＯＦ ＭＥＤＩＣＩＮＥ, vol. 369, no. 18, JPN6018019889, 2013, pages 1691 - 1703, ISSN: 0003807330
ＡＮＴＩＣＡＮＣＥＲ ＲＥＳＥＡＲＣＨ, vol. 30, no. 11, JPN6018019892, 2010, pages 4619 - 4624, ISSN: 0003807331
Attorney, Agent or Firm:
Ito On